Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: Froma stemcell derived cardiomyocyte-based model to clinical biomarkers of disease outcome

European Heart Journal

Volumn 38, Issue 19, 2017, Pages 1498-1508

  Akdis, Deniz ^a   Saguner, Ardan M ^a   Shah, Khooshbu ^b   Wei, Chuanyu ^b   Medeiros Domingo, Argelia ^c   Von Eckardstein, Arnold ^d,e   Lüscher, Thomas F ^a,e   Brunckhorst, Corinna ^a   Chen, H S Vincent ^b   Duru, Firat ^a,e  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Arrhythmic outcome; Dysplasia; Right ventricular cardiomyopathy; Risk stratification; Sex hormones

Indexed keywords

ANDROSTENEDIONE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; ESTRADIOL; GLUCOSE; INSULIN; LIPID; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; TROPONIN T;

ADULT; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CHOLESTEROL BLOOD LEVEL; CLINICAL OUTCOME; DESMOSOME; ESTRADIOL BLOOD LEVEL; FEMALE; GENE MUTATION; GLUCOSE BLOOD LEVEL; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; INDUCED PLURIPOTENT STEM CELL; INSULIN BLOOD LEVEL; LIPID STORAGE; LIPOGENESIS; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUDDEN CARDIAC DEATH; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS OF VARIANCE; BIOLOGICAL MODEL; BLOOD; EXERCISE; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; SEXUAL CHARACTERISTICS;

ADULT; ANALYSIS OF VARIANCE; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; BIOMARKERS; DEATH, SUDDEN, CARDIAC; DESMOSOMES; ESTRADIOL; EXERCISE; FEMALE; GONADAL STEROID HORMONES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; PROGNOSIS; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 85039048160     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehx011     Document Type: Article

References (40)

1. Saguner AM, Duru F, Brunckhorst CB. Arrhythmogenic right ventricular cardiomyopathy: A challenging disease of the intercalated disc. Circulation 2013;128:1381-1386.
2. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996;335:1190-1196.
3. Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S, Kan NG, Forcales S, Puri PL, Leone TC, Marine JE, Calkins H, Kelly DP, Judge PJ, Chen H-SV. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 2013;494:105-110.
4. Akdis D, Medeiros-Domingo A, Gaertner-Rommel A, Kast JI, Enseleit F, Bode P, Klingel K, Kandolf R, Renois F, Andreoletti L, Akdis CA, Milting H, Lüscher TF, Brunckhorst C, Saguner AM, Duru F. Myocardial expression profiles of candidate molecules in arrhythmogenic right ventricular cardiomyopathy/dysplasia compared with dilated cardiomyopathy and healthy controls. Heart Rhythm 2016;13:731-741.
5. Bhonsale A, Groeneweg JA, James CA, Dooijes D, Tichnell C, Jongbloed JD, Murray B, Te Riele AS, van den Berg MP, Bikker H, Atsma DE, de Groot NM, Houweling AC, van der Heijden JF, Russell SD, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Calkins H, Hauer RN. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-Associated mutation carriers. Eur Heart J 2015;36:847-855.
6. Saguner AM, Medeiros-Domingo A, Schwyzer MA, On CJ, Haegeli LM, Wolber T, Hürlimann D, Steffel J, Krasniqi N, Rüeger S, Held L, Lüscher TF, Brunckhorst C, Duru F. Usefulness of inducible ventricular tachycardia to predict long-Term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 2013;111:250-257.
7. Saguner AM, Ganahl S, Kraus A, Baldinger SH, Akdis D, Saguner AR, Wolber T, Haegeli LM, Steffel J, Krasniqi N, Lüscher TF, Tanner FC, Brunckhorst C, Duru F. Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia. BMC Cardiovasc Disord 2015;15:4.
8. Saguner AM, Vecchiati A, Baldinger SH, Rüeger S, Medeiros-Domingo A, Mueller-Burri AS, Haegeli LM, Biaggi P, Manka R, Lüscher TF, Fontaine G, Delacrétaz E, Jenni R, Held L, Brunckhorst C, Duru F, Tanner FC. Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Cardiovasc Imaging 2014;7:230-239.
9. Rigato I, Bauce B, Rampazzo A, Zorzi A, Pilichou K, Mazzotti E, Migliore F, Marra MP, Lorenzon A, De Bortoli M, Calore M, Nava A, Daliento L, Gregori D, Iliceto S, Thiene G, Basso C, Corrado D. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet 2013;6:533-542.
10. Ruwald AC, Marcus F, Estes NA, Link M, McNitt S, Polonsky B, Calkins H, Towbin JA, Moss AJ, Zareba W. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: Results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2015;36:1735-1743.
11. James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, Tedford RJ, Judge DP, Calkins H. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-Associated desmosomal mutation carriers. J Am Coll Cardiol 2013;62:1290-1297.
12. Meyer S, van der Meer P, van Tintelen JP, van den Berg MP. Sex differences in cardiomyopathies. Eur J Heart Fail 2014;16:238-247.
13. Bauce B, Frigo G, Marcus FI, Basso C, Rampazzo A, Maddalena F, Corrado D, Winnicki M, Daliento L, Rigato I, Steriotis A, Mazzotti E, Thiene G, Nava A. Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women. Am J Cardiol 2008;102:1252-1257.
14. Chen SN, Gurha P, Lombardi R, Ruggiero A, Willerson JT, Marian AJ. The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Res 2014;114:454-468.
15. Asimaki A, Kapoor S, Plovie E, Karin Arndt A, Adams E, Liu Z, James CA, Judge DP, Calkins H, Churko J, Wu JC, MacRae CA, Kléber AG, Saffitz JE. Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Sci Transl Med 2014;6:240-274.
16. Mauvais-Jarvis F. Estrogen and androgen receptors: Regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab 2011;22:24-33.
17. Herring MJ, Oskui PM, Hale SL, Kloner RA. Testosterone and the cardiovascular system: A comprehensive review of the basic science literature. J Am Heart Assoc 2013;2:e000271.
18. Magnani JW, Moser CB, Murabito JM, Sullivan LM, Wang N, Ellinor PT, Vasan RS, Benjamin EJ, Coviello AD. Association of sex hormones, aging, and atrial fibrillation in men: The framingham heart study. Circ Arrhythm Electrophysiol 2014;7:307-312.
19. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNcaP. Cancer Res 1997;57:1086-1090.
20. Payne JR, Kotwinski PJ, Montgomery HE. Cardiac effects of anabolic steroids. Heart 2004;90:473-475.
21. Giordano S, Hage FG, Xing D, Chen YF, Allon S, Chen C, Oparil S. Estrogen and cardiovascular disease: is timing everything? Am J Med Sci 2015;350:27-35.
22. Narayanan K, Havmoeller R, Reinier K, Jerger K, Teodorescu C, Uy-Evanado A, Navarro J, Huertas-Vazquez A, Gunson K, Jui J, Chugh SS. Sex hormone levels in patients with sudden cardiac arrest. Heart Rhythm 2014;11:2267-2272.
23. Hu X, Jiang H, Xu C, Zhou X, Cui B, Lu Z. Relationship between sex hormones and idiopathic outflow tract ventricular arrhythmias in adult male patients. Transl Res 2009;154:265-268.
24. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur Heart J 2010;31:806-814.
25. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
26. van der Zwaag PA, Jongbloed JD, van den Berg MP, van der Smagt JJ, Jongbloed R, Bikker H, Hofstra RM, van Tintelen JP. A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Hum Mutat 2009;30:1278-1283.
27. Medeiros-Domingo A, Saguner AM, Magyar I, Bahr A, Akdis D, Brunckhorst C, Duru F, Berger W. Arrhythmogenic right ventricular cardiomyopathy: implications of next-generation sequencing in appropriate diagnosis. Europace 2016;5:1532-2092.
28. Ayaz O, Howlett SE. Testosterone modulates cardiac contraction and calcium homeostasis: cellular and molecular mechanisms. Biol Sex Differ 2015;6:9.
29. Parks RJ, Howlett SE. Sex differences in mechanisms of cardiac excitationcontraction coupling. Pflugers Arch 2013;465:747-763.
30. Brouillette J, Rivard K, Lizotte E, Fiset C. Sex and strain differences in adult mouse cardiac repolarization: importance of androgens. Cardiovasc Res 2005;65:148-157.
31. Fischer TH, Herting J, Eiringhaus J, Pabel S, Harmann NH, Ellenberger D, Friedrich M, Renner A, Gummert J, Maier LS, Zabel M, Hasenfuss G, Sossalla S. Sex-dependent alterations of Ca2 cycling in human cardiac hypertrophy and heart failure. Europace 2016;18:1440-1448.
32. Veldhuis JD, Keenan DM, Liu PY, Iranmanesh A, Takahashi PY, Nehra AX. The aging male hypothalamic-pituitary-gonadal axis: pulsatility and feedback. Mol Cell Endocrinol 2009;299:14-22.
33. Tsai WC, Lee TI, Chen YC, Kao YH, Lu YY, Lin YK, Chen SA, Chen YJ. Testosterone replacement increases aged pulmonary vein and left atrium arrhythmogenesis with enhanced adrenergic activity. Int J Cardiol 2014;176:110-118.
34. La Colla A, Vasconsuelo A, Milanesi L, Pronsato L. 17b-Estradiol Protects Skeletal Myoblasts from Apoptosis through P53, BCL-2 and FoxO Families. J Cell Biochem 2017;118:104-115.
35. Mannic T, Viguie J, Rossier MF. In vivo and in vitro evidences of dehydroepiandrosterone protective role on the cardiovascular system. Int J Endocrinol Metab 2015;13:e24660.
36. Tint AN, Hoermann R, Wong H, Ekinci EI, MacIsaac RJ, Jerums G, Zajac JD, Grossmann M. Association of sex hormone-binding globulin and free testosterone with mortality in men with type 2 diabetes mellitus. Eur J Endocrinol 2016;174:59-68.
37. Link MS, Laidlaw D, Polonsky B, Zareba W, McNitt S, Gear K, Marcus F, Estes NA. Ventricular arrhythmias in the north american multidisciplinary study of arvc: predictors, characteristics, and treatment. J Am Coll Cardiol 2014;64:119-125.
38. Horjen AW, Ulimoen SR, Enger S, Berge T, Ihle-Hansen H, Norseth J, Tveit A. Impact of atrial fibrillation on levels of high-sensitivity troponin i in a 75-year-old population. Scand J Clin Lab Invest 2015;75:308-313.
39. Sato K, Iemitsu M. Exercise and sex steroid hormones in skeletal muscle. J Steroid Biochem Mol Biol 2015;145:200-205.
40. Corrado D, Wichter T, Link MS, Hauer R, Marchlinski F, Anastasakis A, Bauce B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C, Pelliccia A, Duru F, Protonotarios N, Estes NM, McKenna WJ, Thiene G, Marcus FI, Calkins H. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: An international task force consensus statement. Circulation 2015;132:441-453.